Navigation Links
HeartWare International Reports Fourth Quarter 2012 Revenue Of $32.7 Million; Full Year 2012 Revenue Of $110.9 Million
Date:2/27/2013

e, in fiscal 2011.

At December 31, 2012, the Company had $102.8 million of cash, cash equivalents and investments.

HeartWare will host a conference call on Wednesday, February 27, 2013 at 8:30 a.m., U.S. Eastern Standard Time to discuss the Company's financial results, highlights from the fourth quarter and business outlook.  The call may be accessed by dialing 1-888-846-5003 five minutes prior to the scheduled start time and referencing "HeartWare."  For callers outside the U.S., please dial +1-480-629-9856.

A live webcast of the call will also be available at the Company's website (www.heartware.com) by selecting "HeartWare Fourth Quarter 2012 Conference Call" under the section titled "Corporate Presentations" on the Home Page.  A replay of the conference call will be available through the above weblink immediately following completion of the call.

About HeartWare InternationalHeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure. The HeartWare® Ventricular Assist System features the HVAD® pump, a small full-support circulatory assist device designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices. The HeartWare System is approved in the United States for the intended use as a bridge to cardiac transplantation in patients who are at risk of death from refractory end-stage left ventricular heart failure, has received CE Marking in the European Union and has been used to treat patients in 28 international countries. The device is also currently the subject of a U.S. clinical trial for destination therapy. For additional information, please visit the Company's website at www.heartware.com.
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. HeartWare Schedules Fourth Quarter Conference Call and Webcast
2. HeartWare Presentation at Leerink Swann Global Healthcare Conference to be Webcast
3. HeartWare Presentation at the Oppenheimer 23rd Annual Healthcare Conference to be Webcast
4. HeartWare Presentation At The 24th Annual Piper Jaffray Healthcare Conference To Be Webcast
5. HeartWare Presentation At The Lazard Capital Markets 9th Annual Healthcare Conference To Be Webcast
6. HeartWare Reports Third Quarter 2012 Results
7. HeartWare Schedules Third Quarter Conference Call And Webcast
8. HeartWare Presentation at the UBS Global Life Sciences Conference to be Webcast
9. HeartWare Presentation At The Canaccord Genuity 32nd Annual Growth Conference To Be Webcast
10. HeartWare Presentation at the 2012 Wedbush PacGrow Lifesciences Management Access Conference to be Webcast
11. HeartWare Reports Second Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... HOUSTON , July 28, 2014  Houston ... announces that he offers orthodontic treatment with Invisalign. ... area patients can have their teeth straightened without ... same long-term benefits associated with other types of ... enjoy natural looks in addition to better support ...
(Date:7/28/2014)... ResMed (NYSE: RMD ), innovatore e pioniere ... respiratori del sonno (SDB) e altre patologie croniche del ... il produttore Taiwanese di dispositivi medicali, APEX Medical Corp. ... in testa, che violano i brevetti, utilizzate con l,APEX ... Corte Regionale Distrettuale di Monaco , ...
(Date:7/28/2014)... England , July 28, 2014 /PRNewswire/ ... dass Albion Ventures 2,5 Millionen £ investiert ... in der Konsumgüter-, Gesundheits-, Pharma- und Logistikbranche ... Ventures.      (Photo: http://photos.prnewswire.com/prnh/20140728/697982 ... 18 Monaten hat OmPrompt sein beschleunigtes Wachstum ...
Breaking Medicine Technology:Houston Cosmetic Dentist, Dr. Behzad Nazari, Now Offers Orthodontic Treatment with Invisalign 2ResMed riceve un'ingiunzione permanente contro APEX in Germania, continua a far valere i propri diritti per i brevetti in Europa 2OmPrompt erhält Finanzierung für Marktexpansion von Kundenautomatisierungsmanagement 2
... July 7, 2011 Watson Pharmaceuticals, Inc. (NYSE: ... subsidiary, Watson Laboratories, Inc., filed an Abbreviated New ... Drug Administration (FDA) seeking approval to market lisdexamfetamine ... generic version of Shire LLC,s Vyvanse®. Vyvanse® is ...
... 7, 2011 The U.S. Food and Drug Administration ... exercise enforcement discretion with respect to the premarket notification ... radiology devices with well-established safety and effectiveness profiles. ... The draft guidance lists 30 different device types, including ...
Cached Medicine Technology:Watson Confirms Vyvanse® Patent Challenge 2FDA Proposes New Policy for Some Diagnostic and Radiology Devices 2
(Date:7/28/2014)... are on the cusp of revolutionizing health care, armed ... from cardiac measurements to sonograms. , While tremendous potential ... costs, several health law experts say in a just-published ... that more oversight is needed by the U.S. Food ... safety. Out of some 100,000 mHealth apps on the ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 According ... Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition ... ALD), Product (Power, Opto-electronic), Application, and Geography-2013-2020", published ... at a CAGR of 12.63% from 2014 to ... Browse 121 market data tables and 88 figures ...
(Date:7/28/2014)... July 28, 2014 According to a ... Solution Software Market- Global Industry Analysis, Size, Share, Growth, ... device market was valued at USD 3,005 million in ... of 13.8% from 2014 to 2020, to reach an ... Globally, the e-clinical solution software market is witnessing significant ...
(Date:7/28/2014)... in Taiwan has developed a new optical technology that ... diabetes sooner, when it is more easily treated. If ... it may pave the way for the early detection ... autonomic neuropathy, which is common among people with both ... affects the autonomic nerves controlling vital organs like the ...
(Date:7/28/2014)... Axiom EPM , a leading ... performance management software for enterprises, today announced that it ... that surpassed its record Q1 results, and adding more ... this growth to increased demand for its comprehensive suite ... addition of incremental solutions for existing customers. New clients ...
Breaking Medicine News(10 mins):Health News:Booming mobile health app market needs more FDA oversight for consumer safety, confidence 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 3Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 4Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4Health News:Wearable device for the early detection of common diabetes-related neurological condition 2Health News:Axiom EPM Announces Record Second Quarter of 2014 2
... seems to be reaching epidemic proportions, forcing changes in ... are now revamping their fleet of ambulances to cope ... ,Super-sized vehicles have been introduced and new air ... ambulances will now be equipped with heavy-duty stretchers, capable ...
... has approved four new drugs manufactured by the Macleods of ... of the four would be used against some strains of ... these four medicines will reinforce efforts to scale up access ... a statement. ,The medicines are the first TB ...
... While it is well known that genetics and family history ... lifestyle choices which include diet//, exercise and environment, do play ... session of the American College of Cardiology looked at many ... person’s chances of being diagnosed with heart disease. ...
... claim that they can efficiently seek out and kill ... very similar to the Nature's way of distinguishing one ... tumor targeting strategy, presented today (March 25) at the ... harnesses one of the body's natural antibodies and immune ...
... has sought for more organ donations so as to meet ... According to him there is a big gap between the ... ,Statistics reveal that 1.5 million patients need organ transplants each ... In China organs are donated by people after signing voluntary ...
... all mental health units in England and Wales revealed ... This is much against the government’s claim that this ... ,The healthcare commission reports that 55% of in-patients are ... opposite sex. This practice has resulted in an increase ...
Cached Medicine News:Health News:Indian Pharma Authorized to Market New Anti-TB Drugs 2Health News:Role of Lifestyle Choices in Heart Risks 2Health News:Role of Lifestyle Choices in Heart Risks 3Health News:Tumors Targeted Naturally 2Health News:Tumors Targeted Naturally 3
... operating and recovery room, ,The Cardiocap ... haemodynamic and airway gas monitoring for induction ... units. The Cardiocap II is available in ... haemodynamic measurements. Two of the models include ...
Precordial Chestpieces are manufactured from chrome plated brass. Provides a hollow design with deep sound chambers for optimum acoustics....
For accurately monitoring heart and breath sounds....
For accurately monitoring core temperature and heart and breath sounds....
Medicine Products: